School of Medicine
Showing 401-420 of 518 Results
-
Hiroyuki Shimada
Professor of Pathology
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Richard Sibley
Professor of Pathology, Emeritus
Current Research and Scholarly InterestsImmunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders.
-
Arend Sidow
Professor of Pathology and of Genetics
On Leave from 04/01/2024 To 02/21/2025Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.
More information can be found here: http://www.sidowlab.org -
Oscar Silva
Clinical Assistant Professor, Pathology
BioOscar is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from UCLA. His interests include immunology, the pathogenesis and diagnosis of lymphomas, and global health.
-
Raymond A. Sobel, M.D.
Professor of Pathology
Current Research and Scholarly InterestsWe study cellular and molecular mechanisms of immune-mediated injury in CNS tissues that are affected in multiple sclerosis (MS). We study: 1) tissues of mice with EAE using histology and immunohistochemistry, 2) cross-recognition of neurons by antibodies against myelin proteolipid protein epitopes, and a distinct oligodendrogliopathy induced in mice by the non-protein amino acid azetidine (Aze), (which is found in the human diet); Aze-induced abnormalities mimic those in MS patient CNS tissues
-
Clara Sökler Sanchez
Graduate, Medicine, Pathology
BioVisiting Student Researcher in Lab of Dr. Christoph Thaiss at the Arc Institute
-
Melissa Steele-Ogus
Postdoctoral Scholar, Pathology
BioMelissa Steele-Ogus grew up in Berkeley, California. She received a BS in Environmental Sciences and BA in Molecular Biology from the University of California, Berkeley, in 2012. She earned a PhD in Biology from the University of Washington in 2021, studying the actin cytoskeleton of Giardia lamblia. In her free time, she enjoys dancing, baking, and birdwatching. She may be secretly some sort of weird bug, but probably isn't.
-
Henning Stehr
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsBioinformatics & Clinical Cancer Genomics
-
David Steiner
Adjunct Clinical Assistant Professor, Pathology
Current Research and Scholarly InterestsMechanistic and translational studies to better understand the functional and clinical implications of somatic mutations in aging and cancer.
